2018
DOI: 10.1038/s41598-018-22525-0
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the therapeutic effects of QuickOpt optimization in Chinese patients with chronic heart failure treated by cardiac resynchronization

Abstract: In this trial, long-term therapeutic effects and clinical improvements in Chinese chronic heart failure patients optimized by QuickOpt or echocardiography were compared for atrioventricular (AV) and interventricular (VV) delay optimizations after cardiac resynchronization therapy (CRT) with pacing (CRT-P) or with pacing and defibrillator (CRT-D) therapy. One hundred and ninety-six subjects (50%) had dilated cardiomyopathy, 108 (27.6%) had ischemic heart disease and 112 (28.6%) were hypertensive and were random… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(14 citation statements)
references
References 20 publications
(20 reference statements)
0
13
0
Order By: Relevance
“…In a subgroup of 25 patients, device settings were optimized by maximizing the invasively determined maximal rate of LV pressure rise (dP/dt max ) during the implantation procedure [ 17 ]. In the remaining 10 patients, algorithms based on the intracardiac electrogram implemented in the devices were used for device optimization [ 18 ]. Echocardiographic response to CRT was assessed by the reduction in LV end-systolic volume, with responders defined as patients with > 15% reduction at 6 months (“long-term”) follow-up [ 19 ].…”
Section: Methodsmentioning
confidence: 99%
“…In a subgroup of 25 patients, device settings were optimized by maximizing the invasively determined maximal rate of LV pressure rise (dP/dt max ) during the implantation procedure [ 17 ]. In the remaining 10 patients, algorithms based on the intracardiac electrogram implemented in the devices were used for device optimization [ 18 ]. Echocardiographic response to CRT was assessed by the reduction in LV end-systolic volume, with responders defined as patients with > 15% reduction at 6 months (“long-term”) follow-up [ 19 ].…”
Section: Methodsmentioning
confidence: 99%
“…Two main factors that determine better outcomes are the optimization of atrial-to-ventricular (AV) and ventricular-to-ventricular (VV) delay (Naqvi et al, 2006). Reviewing the literature on echocardiography versus IEGM-based optimization of CRT, we found out that programming can be performed with the IEGM-based algorithm and the results are comparable with the optimization performed with the echocardiogram (Baker et al, 2007;Giammaria et al, 2016;Hua et al, 2012;Jensen et al, 2011;Kamdar et al, 2010;Pezo Nikolić et al, 2017;Reinsch et al, 2009;Sawhney et al, 2004;Wang et al, 2013;Yan et al, 2018;Zhang et al, 2019). Usually, passive ventricular filling occurs in early and mid-diastolic phases, with the blood flowing from the atrium to the ventricle secondary to AV pressure difference.…”
Section: Discussionmentioning
confidence: 87%
“…Intracardiac electrocardiogram uses different timing cycle optimization algorithms that rapidly determine optimal AV and VV intervals based on heart electrical activity (Abraham et al, 2010;AlTurki et al, 2019;Hu et al, 2022;Wang et al, 2020;Yan et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…However, complex electrocardiographic algorithms to set the AV delay, such as Smart-AV and QuickOpt, failed to “optimize” response rates in randomized controlled trials [6, 28]. In this regard, a recent multicenter study reported that NYHA class, specific activity scale (SAS), and 6MWT improved similarly at 12 months in the groups optimized by QuickOpt or echocardiography, although there was a significant difference in the time required for optimization by QuickOpt [34]. A randomized study to compare VV optimization to default simultaneous biventricular pacing also showed that selecting the VV according to pulsed Doppler echocardiography had no clinical benefit at the 6-month follow-up [35].…”
Section: Discussionmentioning
confidence: 99%